Advanced Search
Contact | Corporate | Help

News Archive of OnBioVC

ArticleAdded
S.E.A. Medical Systems, Inc.: Series B $3M05-21-12
Phosphate Therapeutics, Ltd.: Series A $13.8M05-21-12
CrystalGenomics, Inc.: Series A $2.6M05-21-12
Heat Biologics, Inc.: Series A $2.8M05-21-12
CN Creative, Ltd: Series A $3.1M05-21-12
Mevion Medical Systems, Inc.: Series G $45M05-21-12
ImmuneXcite, Inc.: Series A $2.4M04-24-12
AirXpanders, Inc.: Series D $10.3M04-24-12
MC10, Inc.: Series B $2M04-24-12
CN Creative, Ltd.: Series A $3.1M04-24-12
SEA Medical Systems, Inc.: Series B $3M04-24-12
CytoPherx, Inc.: Series C $34M04-23-12
MedGenesis Therapeutix, Inc.: Series C $5M04-23-12
Natura, Inc.: Series D $20M04-23-12
Pulse Therapeutics, Inc.: Series B $3.1M04-23-12
3-V Biosciences, Inc.: Series C $20M04-23-12
Akebia Therapeutics, Inc.: Series B $4.1M04-19-12
1Q12 White Paper | A is for Innovation And?03-14-12
Promedior, Inc.: Series D $21.5M03-13-12
Collegium Pharmaceutical, Inc.: Series B $22.5M03-12-12
BioAmber, Inc.: Series C $30M03-12-12
LanzaTech, Ltd.: $55.8M Series C03-09-12
PowerVision, Inc.: Series C $37.2M03-09-12
Warp Drive Bio, LLC: Series A $75M03-07-12
GlySure, Ltd.: Series C $10.9M03-07-12
Aria Diagnostics, Inc.: Series C $52.7M03-06-12
Avinger, Inc.: Series C $22.5M03-06-12
RaNA Therapeutics, Inc.: Series A $20.7M03-05-12
BerGenBio, AS: Series A $8.8M03-05-12
Prosensa Therapeutics, BV: Series A $30.7M03-02-12
PolyPid, Ltd.: Series B $2M03-02-12
Innavirvax, SAS: Series B $4.9M03-01-12
Celladon, Inc.: Series D $43M03-01-12
Oxitec, Ltd.: Series B $12.7M03-01-12
Roka BioScience, Inc.: Series D $27.5M02-29-12
SG Biofuels, Inc.: Series B $17M02-29-12
Telormedix, SA.: Series B $8.3M02-29-12
Pharmalink, AB.: Series C $5.3M02-28-12
Apogenix, GmbH: Series C $10M02-28-12
Physicians Interactive Holdings, Inc.: Series A $8.5M02-28-12
Syndexa Pharmaceuticals Corp.: Series B $8.5M02-27-12
Probiodrug, AG: Series C $20M02-27-12
Elevation Pharmaceuticals, Inc.: Series B $30M02-27-12
OnBioVC 4Q11 & 2011 | Trend Analysis Now Available02-20-12
Arteaus Therapeutics, LLC: Series A $18M02-15-12
100Plus, Inc.: Series A $1.3M02-15-12
EndoEvolution, LLC: Series B $3.3M02-15-12
Cleave Biosciences, Inc.: Series A $44M02-15-12
Firefly BioWorks, Inc.: Series A $2M02-15-12
OvaScience, Inc.: Series A $6M02-15-12
PharmaSecure, Inc.: Series B $3.9M02-15-12
Dermira, Inc.: Series A $42M02-15-12
Apnex Medical, Inc.: Series C $20M02-15-12
MedVentive, Inc.: Series D $12M02-15-12
Phagenesis, Ltd.: Series B $9.2M02-14-12
Advanced ICU Care, Inc.: Series D $8M02-14-12
Viroblock, SA: Series C $3.6M02-14-12
ZeaChem, Inc.: Series C $19M02-14-12
Sage Therapeutics, Inc.: Series A $35M02-14-12
Foundation Medicine, Inc.: Series A $16M02-14-12
Atlanta Catheter Therapies, Inc.: Series A $2.9M02-14-12
Imagen Biotech, Inc.: Series A $40M02-14-12
480 Biomedical, Inc.: Series A $15M02-14-12
Azelon Pharmaceuticals, Inc.: Series A $4.5M02-14-12
Arsenal Medical, Inc.: Series A $3M02-14-12
Creabilis, SA: Series B $20M02-14-12
Radius Health, Inc.: Series C $21.4M02-13-12
Selecta Biosciences, Inc.: Series D $22M02-13-12
Bind Biosciences, Inc.: Series D $25.5M02-13-12
NxThera, Inc.: Series B $9M02-13-12
Hookipa Biotech, GmbH: Series A $9.7M02-13-12
LipoFIT Analytic, GmbH: Series B $9.5M02-13-12
simplifyMD, Inc.: Series A $4.5M02-13-12
Chromatin, Inc.: Series D $10.4M02-13-12
Dfine, Inc.: Series E $25M02-13-12
CV Ingenuity, Inc.: Series B $16M02-13-12
TrialReach, Ltd.: Series A $1.2M02-13-12
Functional Neuromodulation, Inc.: Series A $10.4M02-10-12
Uptake Medical, Inc.: Series C $35M02-10-12
Topica Pharmaceuticals, Inc.: Series B $27M02-10-12
GenoLogics, Inc.: Series D $8M02-10-12
Courtagen Life Sciences, Inc.: Series B $8M02-10-12
DNAnexus, Inc.: Series B $15M02-10-12
Clear Catheter Systems, Inc.: Series C $4.9M02-09-12
Intimate Bridge 2 Conception, Inc.: Series A $5M02-09-12
Cool Planet BioFuels, Inc.: Series B $17.7M02-09-12
NexSteppe, Inc.: Series B $14M02-09-12
PatientKeeper, Inc.: Series G $6M02-09-12
Medrobotics Corporation: Series C $11.7M02-09-12
Allena Pharmaceuticals, Inc.: Series A $15M02-08-12
Medivo, Inc.: Series A $7M02-08-12
NuCana BioMed, Ltd.: Series A $10.4M02-08-12
Biocartis, SA.: Series C $100M02-08-12
AcuFocus, Inc.: Series F $40M02-08-12
Oxyrane, Ltd.: Series D $26.5M02-08-12
TransEnterix, Inc.: Series B $15M02-07-12
Avraham Pharmaceuticals, Ltd.: Series B $3M02-07-12
Medley Health, Inc.: Series A $20M02-07-12
Pixeon, Ltda.: Series C $25M02-07-12
Sera Prognostics, Inc.: Series A $19.3M02-07-12
Cohera Medical, Inc.: Series C $25M02-07-12
IntegenX, Inc.: Series C $40M02-06-12
Verona Pharma, Ltd.: Series A $11.5M02-06-12
Aratana Therapeutics, Inc.: Series B $15.5M02-06-12
ImmusanT, Inc.: Series A $20M02-06-12
Sotera Wireless, Inc.: Series D $12.2M02-06-12
Catabasis Pharmaceuticals, Inc.: Series A $8M02-06-12
Ember Therapeutics, Inc.: Series A $34.1M02-04-12
CeNeRx BioPharma, Inc.: Series D $4.6M02-03-12
MedLumics: Series A $4.7M02-03-12
CircuLite, Inc.: Series D $30M02-03-12
TopiVert, Ltd.: Series A $12.5M02-03-12
HealthTap, Inc.: Series A $11.5M02-03-12
C8 MediSensors, Inc.: Series E $24M02-03-12
Tangent Medical Technologies, Inc.: Series A $4.5M02-02-12
Inova Labs, Inc.: Series B $17.5M02-02-12
Pivot Medical, Inc.: Series C $32M02-02-12
Leonardo Biosystems, Inc.: Series A $1.25M02-02-12
Cervilenz, Inc.: Series A $8.4M02-02-12
Sensors for Medicine and Science, Inc.: Series D $54.1M02-02-12
Provenance Biopharmaceuticals, Corp.: Series A $8M01-31-12
Excelimmune, Inc.: Series C $12M01-31-12
Neuraltus Pharmaceuticals, Inc.: Series B $9.6M01-31-12
Atox Bio.: Series A $3.25M01-31-12
Aviir, Inc.: Series E $10M01-31-12
Groove Biopharma, Inc.: Series B $6M01-31-12
Acceleron Pharma, Inc.: Series D $30.4M01-31-12
Agios Pharmaceuticals, Inc.: Series C $78M01-31-12
PharmacoFore, Inc.: Series A $10M01-31-12
Portola Pharmaceuticals, Inc.: Series E $89M01-31-12
Cytoo, SA: Series C $10M01-31-12
AuraSense Therapeutics, LLC: Series B $5.4M01-31-12
PathoGenetix, Inc.: Series B $7.5M01-30-12
NanoString Technologies, Inc.: Series D $20M01-30-12
Karyopharm Therapeutics, Inc.: Series A $10M01-30-12
arGEN-X, BV: Series B $37M01-30-12
Innopharma, Inc.: Series A $15M01-30-12
Cerulean Pharma, Inc.: Series D $15M01-30-12
Antisense Pharma, GmbH: Series F $11M01-26-12
Edison Pharmaceuticals, Inc.: Series E $4.1M01-26-12
Zafgen, Inc.: Series C $33M01-26-12
Breathe America, Inc.: Series B $22M01-26-12
Pharnext, SAS: Series B $3.5M01-26-12
PolyTherics, Ltd.: Series C $3.5M01-26-12
SeeChange Health, Inc.: Series B $20M01-26-12
Intervention Insights, Inc.: Series B $7.2M01-26-12
nanoMR, Inc.: Series B $13M01-26-12
Circle Cardiovascular Imaging, Inc.: Series B $3.9M01-26-12
SARcode, Inc.: Series B $44M01-26-12
Intuity Medical, Inc.: Series D $12M01-23-12
Cleveland Heartlab, Inc.: Series B $18.4M01-23-12
Monteris Medical, Inc.: Series C $8.6M01-19-12
Sorbent Therapeutics, Inc.: Series B01-19-12
OnBioVC: End Piracy, Not Liberty01-18-12
Verastem, Inc.: Series B $32M01-17-12
Transcend Medical, Inc.: Series B $16M01-17-12
NABsys, Inc.: Series C $10M01-17-12
Horizon Discovery, Ltd.: Series C $18.6M01-16-12
OPX Biotechnologies, Inc.: Series C $36.5M01-16-12
SpineVision, SA: Series B $5M01-16-12
Avedro, Inc.: Series C $25M01-16-12
SpringLeaf Therapeutics, Inc.: Series B $4M01-16-12
SurgiQuest, Inc.: Series D $19M01-16-12
LifeBond, Ltd.: Series C $20M01-12-12
Restoration Robotics, Inc.: Series C $41M01-12-12
PathoGenetiX, Inc.: Series B $4M01-12-12
NanoDetection Technology, Inc. Series A $2.3M01-12-12
Second Genome, Inc.: Series A $5M01-12-12
Ceptaris Therapeutics, Inc.: Series D $14.4M01-12-12
Enobia Pharma, Inc.: Series D $40M01-12-12
Pulmatrix, Inc.: Series B $14M01-12-12
Embera NeuroTherapeutics, Inc.: Series A $4.5M01-10-12
SironRx Therapeutics, Inc.: Series A $3.4M01-10-12
Affinium Pharmaceuticals, Inc.: Series B $15M01-10-12
Spinifex Pharmaceuticals, Ltd.: Series B $6.401-09-12
Entellus Medical, Inc.: Series E $35M01-09-12
Awarepoint Corp.: Series F $27M01-09-12
AliveCor, Inc.: Series A $3M01-09-12
SpineGuard, Inc.: Series B $6.2M01-06-12
Independa, Inc.: Series A $1.6M01-06-12
Zymeworks, Inc.: Series D $8.1M01-06-12
2012 OnBioVC Status Report #101-03-12
***HELP WANTED*** OnBioVC Wants You!01-03-12
Metabolon, Inc.: Series D $13.1M11-21-11
ZocDoc, Inc.: Series C $25M11-21-11
Allegro Diagnostics, Inc.: Series A $5.4M11-10-11
Acutus Medical, Inc.: Series A $1M11-10-11
NanoDetection Technology, Inc.: Series A $2.3M11-10-11
Mosaic Biosciences, Inc.: Series A $1M11-08-11
Precision Biopsy, Inc.: Series A $2.5M11-08-11
Surefire Medical, Inc.: Series A $6.1M11-08-11
Nevro Corp.: Series B $58M10-30-11
Elevation Pharmaceuticals, Inc.: Series A $17M10-27-11
Kythera Biopharmaceuticals, Inc.: Series D $37.4M10-25-11
Clinipace Worldwide, Inc.: Series C $15M10-24-11
Tensha Therapeutics, Inc.: Series A $15M10-21-11
Tokai Pharmaceuticals, Inc.: Series D $23M10-20-11
Siluria Technologies, Inc.: Series B $20M10-19-11
CareCloud, Inc.: Series A $20.1M10-18-11
MSI Methylation Sciences, Inc.: Series A $18.2M10-17-11
Teladoc, Inc.: Series D $18.6M10-14-11
RF Surgical Systems, Inc.: Series B $12M10-13-11
Miracor Medical Systems, GmbH: Series B $10M10-12-11
AM-Pharma, NV: Series D $39.8M10-11-11
OnBioVC | State of the State ? Sound the Alarms!10-07-11
OnBioVC | State of the State ? Sound the Alarms10-07-11
Amakem, NV: Series A $25.3M10-07-11
Crescendo Bioscience, Inc.: Series C $31M10-06-11
Theraclone Sciences, Inc.: Series B $10.6M10-05-11
Valeritas, Inc.: Series C $150M10-04-11
Putney, Inc.: Series C $21M10-03-11
Si-Bone, Inc.: Series C $16M09-28-11
Simpirica Spine, Inc.: Series B $22M09-27-11
CardioKinetix, Inc.: Series E $44M09-26-11
One Last Chance to be Heard?09-26-11
Please Respond (and Win!) | 5 Question New Product Survey09-19-11
OnBioVC Wants You! (?To Be Heard)09-19-11
OnBioVC 2Q11 | Trend Analysis Now Available09-06-11
Adaptive TCR Corp.: Series B $5.8M08-31-11
Access Scientific, Inc.: Series C $10M08-30-11
Stratos Genomics, Inc.: Series A $2.1M08-30-11
ProtonMedia, Inc.: Series B $4.5M08-31-11
Ambit Biosciences, Inc. Series D $30M08-31-11
CryoXtract, Inc.: Series A $3M09-01-11
Milestone Pharmaceuticals, Inc.: Series B $13M09-01-11
Advance Medical, Inc.: Series A $6M08-31-11
Jan Medical, Inc.: Series A $3.1M09-01-11
RF Biocidics, Inc.: Series B $10M09-01-11
Lotus Tissue Repair, Inc.: Series A $26M08-15-11
Esperance Pharmaceuticals, Inc.: Series B $7.5M08-12-11
Cyterix Pharmaceutics, Inc.: Series A $9.2M08-11-11
Acetylon Pharmaceuticals, Inc.: Series B $27M08-10-11
Sorbent Therapeutics, Inc.: Series B $36M08-09-11
Ultragenyx Pharmaceutical, Inc.: Series A $45M08-07-11
Trillium Therapeutics, Inc.: Series A $1M08-05-11
SpringLeaf Therapeutics, Inc.: Series B $15M08-05-11
Nexstim, Oy: Series D $2.8M08-05-11
Explorys, Inc.: Series C $11.5M08-05-11
OrSense, Ltd.: Series D $18M08-05-11
U-Systems, Inc.: Series D $6.5M08-05-11
Stabilitech, Ltd.: Series C $3.5M08-05-11
ProFibrix, B.V.: Series B $10.6M08-05-11
Q Chip, Ltd.: Series C $6M08-04-11
Ability Network, Inc.: Series C $27M08-04-11
Resolve Therapeutics, Inc.: Series A $2M08-02-11
Oncofactor, Inc.: Series A $2.1M08-02-11
SciFluor Life Sciences, Inc.: Series A $5M08-02-11
Neuronetics, Inc.: Series E $30M08-01-11
Cameron Health, Inc.: Series E $107M08-01-11
Excelimmune, Inc.: Series B $10.5M07-29-11
GenKyoTex, SA: Series C $20.8M07-29-11
Molecular Imaging Research, Inc.: Series A $7M07-29-11
Xlumena, Inc.: Series B $7M07-29-11
Prexa Pharmaceuticals, Inc.: Series B $7M07-28-11
TetraLogic Pharmaceuticals, Inc.: Series C $6M07-28-11
Crown Bioscience, Inc.: Series C $28.8M07-27-11
Naurex, Inc.: Series A $18M07-27-11
Caprotec Bioanalytics, GmbH: Series B $1.4M07-27-11
Delenex Therapeutics, AG: Series A $19.3M07-26-11
Radius Health, Inc.: Series C $66M07-26-11
CardioDx, Inc.: Series E $60M07-25-11
Intrexon Corporation, Inc.: Series E $100M07-25-11
Taris Biomedical, Inc.: Series B $18.3M07-22-11
Benvenue Medical, Inc.: Series C $35.5M07-22-11
Carmell Therapeutics, Inc.: Series A $2.4M07-22-11
Blueprint Medicines, Inc.: Series A $40M07-21-11
PixelOptics, Inc.: Series D $35M07-21-11
Forerun, Inc.: Series C $2M07-21-11
Oxford Nanopore Technologies, Ltd.: Series D $41M07-20-11
Indel Therapeutics, Inc.: Series B $1.4M07-20-11
Aslan Pharmaceuticals, Ltd.: Series A $12M07-20-11
BlueBird Bio, Inc.: Series C $30M07-19-11
Humedica, Inc.: Series B $20M07-19-11
Sangart, Inc.: Series G $50M07-19-11
Akebia Therapeutics, Inc.: Series B $22M07-19-11
CoDa Therapeutics, Inc.: Series B $19.2M07-17-11
F-Star, GmbH: Series B $21.7M07-17-11
Aduro Biotech, Inc.: Series B $19.2M07-17-11
Tracon Pharmaceuticals, Inc.: Series D $14M07-17-11
Conatus Pharmaceuticals, Inc.: Series B $7.5M07-11-11
Mirador Biomedical, Inc.: Series B $1.5M07-08-11
Cellular Dynamics, Inc.: Series C $30M07-07-11
Merrimack Pharmaceuticals, Inc.: Series G $77M07-06-11
Ascletis, Inc.: Series A $100M07-05-11
Tesaro, Inc: Series B $101M07-05-11
Circassia, Ltd.: Series D $98M07-05-11
OnBioVC ? The Happs et. al.06-07-11
OnBioVC 1Q11 | Trend Analysis Now Available05-23-11
Rib-X Pharmaceuticals, Inc.: Series E $20M05-20-11
OrthoSensor, Inc.: Series B $21M05-20-11
TetraLogic Pharmaceuticals, Inc.: Series C $23M05-20-11
Polyplus-Transfection, SA: Series B $3.5M05-20-11
PhysioSonics, Inc.: Series B $3.6M05-20-11
Plasticell, Ltd.: Series A $5.6M05-19-11
Scil Proteins, GmbH: Series B $33.8M05-19-11
Dekkun Corp: Series A $9.9M05-19-11
Mithridion, Inc.: Series C $1.2M05-19-11
SymBio Pharmaceuticals, Ltd.: Series E $24M05-18-11
NeuroPhage Pharmaceuticals, Inc.: Series B $12.4M05-18-11
Conatus Pharmaceuticals, Inc.: Series B $20M05-18-11
Acetylon Pharmaceuticals, Inc.: Series B $12.4M05-18-11
Nimbus Discovery, LLC: Series A $1.5M05-17-11
Acacia Pharma, Ltd.: Series B $10M05-17-11
Anergis, SA: Series A $14.3M05-17-11
Genomatica, Inc.: Series D $45M05-17-11
Stimatix GI, Inc.: Series A $1M05-16-11
BerGenBio, AS: Series A $1.3M05-16-11
VertiFlex, Inc.: Series E $14M05-16-11
Cytovance Biologics, Inc.: Series B $22.5M05-16-11
IntegenX, Inc.: Series B $15.604-29-11
Altacor, Ltd.: Series C $3M04-28-11
Eviagenics, SA: Series A $1.7M04-28-11
Glaukos Corp.: Series E $29.5M04-27-11
Activaero, GmbH: Series B $6.8M04-27-11
Graftys, SA: Series C $5.3M04-26-11
Versartis, Inc.: Series B $21M04-26-11
DBV Technologies, SA: Series C $25.5M04-24-11
PanOptica, Inc.: Series A $30M04-24-11
Aratana Therapeutics, Inc.: Series A $20M04-18-11
Civitas Therapeutics, Inc.: Series A $20M04-18-11
Neuroptix Corp.: Series C $4M04-14-11
NextWave Pharmaceuticals, Inc.: Series C $45M04-13-11
Vaximm, AG: Series B $8M04-12-11
Microvisk Technologies, Ltd.: Series C $9.5M04-11-11
Veniti, Inc.: Series A $14.5M04-08-11
NovaShunt, AG: Series B $25M04-06-11
Kite Pharma, Inc.: Series A $15M04-06-11
SoundCure, Inc.: Series A $3M04-05-11
AssureRx Health, Inc.: Series B $11M04-04-11
Aeternus Biopharma, Ltd.: Series A $499M04-01-11
Core Essence Orthopaedics, Inc.: Series B $11.503-31-11
Synageva BioPharma Corp.: Series C $25M03-30-11
BioNanomatrix, Inc.: Series B $23.3M03-29-11
PanTheryx, Inc.: Series A $1M03-28-11
BridgePoint Medical, Inc.: Series C $9.1M03-25-11
Doximity, Inc.: Series A $10.8M03-24-11
Omthera Pharmaceuticals, Inc.: Series B $33.9M03-23-11
Advanced Animal Diagnostics, Inc.: Series B $11M03-22-11
NxThera, Inc.: Series B $12.6M03-21-11
Retina Implant, AG: Series C $18M03-08-11
Aerie Pharmaceuticals, Inc.: Series B $41.3M03-07-11
Tibion Corp.: Series B $10.2M03-03-11
HTG, Inc.: Series D $15.7M03-02-11
Arsanis, Inc.: Series A $10M03-01-11
Pharmaron Holding, Ltd.: Series C $40M02-28-11
VisionCare Ophthalmic Technologies, Inc.: Series E $31M02-24-11
Ulthera, Inc.: Series C $10.5M02-22-11
Chimerix, Inc.: Series F $45M02-21-11
PneumRx, Inc.: Series C $33M02-16-11
Genocea Biosciences, Inc.: Series B $35M02-15-11
Symphogen, AS: Series F $135.4M02-14-11
4Q10 & 2010 | Trend Analysis Now Available02-08-11
Ocimum Biosolutions, Inc.: Series C $8M01-18-11
Prolong Pharmaceuticals, Inc.: Series C $30M01-18-11
Noxxon Pharma, AG: Series D $2.6M01-18-11
NanoInk, Inc.: Series E $65M01-18-11
Acylin Therapeutics, Inc.: Series A $4.4M01-18-11
ViroXis Corp.: Series A $2.5M01-18-11
Small Bone Innovations, Inc.: Series F $15M01-18-11
23andMe, Inc.: Series C $22M01-18-11
Symetis, SA: Series C $25.8M01-18-11
Hutchinson MediPharma, Ltd.: Series B $12.5M01-18-11
Neograft Technologies, Inc.: Series B $3M01-18-11
Last Call for 2010 Trend Analysis Partners01-13-11
WebPT, Inc.: Series A $1M01-13-11
DICOM Grid, Inc.: Series A $7.5M01-12-11
IDEV Technologies, Inc.: Series D $46M01-12-11
PathCentral, Inc.: Series B $10M01-12-11
Gene Security Network, Inc.: Series C $12M01-12-11
Capella, Ltd.: Series D $14.6M01-12-11
MTM Laboratories, AG: Series C $9M01-11-11
Mind-NRG, SA: Series A $2M01-11-11
Adynxx, Inc.: Series A $4.8M01-11-11
Bonovo Orthopedics, Inc.: Series C $10M01-11-11
RedHill Biopharma, Ltd.: Series B $10M01-11-11
Aires Pharmaceuticals, Inc.: Series B $20M01-10-11
Pearl Therapeutics, Inc.: Series C $69M01-10-11
Denator, AB: Series D $1.7M01-10-11
Kala Pharmaceuticals, Inc.: Series B $3M01-10-11
Covagen, AB: Series A $6.5M01-10-11
Crysalin, Ltd.: Series A $2.4M01-06-11
NovImmune, SA: Series B $20.8M01-05-11
Capricor, Inc.: Series A $2M01-04-11
Accera, Inc.: Series D $11M01-03-11
And That's a Wrap!12-17-10
Minnow Medical, Inc.: Series B $3.2M12-17-10
Sofie Biosciences, Inc.: Series A $2M12-16-10
Tyrx, Inc.: Series C $16M12-15-10
Ortho Kinematics, Inc.: Series B $2M12-14-10
Estech, Inc.: Series D $8.5M12-12-10
Beech Tree Labs, Inc.: Series B $7M12-09-10
Ceregene, Inc.: Series D $11.5M12-08-10
Syntaxin, Ltd.: Series C $28.3M12-07-10
SuperSonic Imagine, SA: Series C $25M12-05-10
Arbor Pharmaceuticals, Inc.: Series B $17.5M12-02-10
Sutro Biopharma, Inc.: Series C $36.5M11-30-10
Helix Therapeutics, Inc.: Series A $2.5M11-29-10
NinePoint Medical, Inc.: Series A $33M11-24-10
Cerenis Therapeutics, SA: Series C $13.6M11-23-10
Dicerna Pharmaceuticals, Inc.: Series B $4M11-22-10
aTyr Pharma, Inc.: Series C $23M11-19-10
Cerulean Pharma, Inc.: Series C $24M11-18-10
Verastem, Inc.: Series A $16M11-17-10
Delenex Therapeutics, AG: Series A $14M11-16-10
nContact Surgical, Inc.: Series D $16M11-15-10
Vascular Pathways, Inc.: $14M Series B11-11-10
Biodesix, Inc.: Series C $7.1M11-11-10
Virtual Incision Corporation: Series A $2M11-10-10
Pathwork Diagnostics, Inc.: Series C $30M11-09-10
Convergence Pharmaceuticals, Ltd.: Series A $35.4M11-07-10
3Q10 OnBioVC | Trend Analysis Now Available11-01-10
DiagnosisOne, Inc.: Series B $5M10-25-10
Cara Therapeutics, Inc.: Series D $15M10-25-10
Euthymics Bioscience, Inc.: Seris A $24M10-25-10
**OnBioVC Post 1,000** AxioMed Spine Corp.: Series D $15M10-25-10
SuperDimension, Inc.: Series B $9.8M10-25-10
Jennerex Biotherapeutics, Inc.: Series D $8.6M10-25-10
***OnBioVC Post #1,000*** AxioMed Spine Corp.: Series D $15M10-25-10
Immune Design Corp.: Series B $32M10-25-10
ClearCount Medical Solutions, Inc.: Series B $5M10-22-10
Anchor Therapeutics, Inc.: Series B $10M10-21-10
Watermark Medical, Inc.: Series B $6M10-21-10
Phreesia, Inc.: Series D $20M10-21-10
Accuri Cytometers, Inc.: Series E $6M10-19-10
Cardioxyl Pharmaceuticals, Inc.: Series C $1510-18-10
Cerenis Therapeutics, SA: Series C $40M10-18-10
NewBridge Pharmaceuticals, Inc.: Series B $12M10-18-10
Tigris Pharmaceuticals, Inc.: Series C $6.5M10-14-10
Auspex Pharmaceuticals, Inc.: $12M Series C10-13-10
Femta Pharmaceuticals, Inc.: Series A $2.2M10-12-10
Femta Pharmaceuticals, Inc.: Series A $22M10-12-10
MerLion Pharmaceuticals Pte. Ltd.: Series C $7M10-11-10
ExcelImmune, Inc.: Series A $4.5M10-11-10
InVasc Therapeutics, Inc.: Series A $3.1M10-08-10
iPierian, Inc.: Series B $6M10-07-10
Horizon Discovery, Ltd.: Series C $9.9M Series C10-06-10
DecImmune Therapeutics, Inc.: Series A $1M10-04-10
TetraLogic Pharmaceuticals, Inc.: Series C $5M10-04-10
Tobria Therapeutics, Inc.: Series B $31M10-01-10
Cylene Pharmaceuticals, Inc.: Series D $12M09-30-10
OpGen, Inc.: Series B $17M09-29-10
CytomX Therapeutics, Inc.: Series B $30M09-28-10
Boston Heart Lab, Inc.: Series C $10M09-27-10
Immatics Biotechnologies, GmbH: Series C $71M09-22-10
Okairos, AG: Series B $20.8M09-21-10
SG Biofuels, Inc.: Series A $9.4M09-20-10
Eddingpharm, Ltd.: Series B $24M09-20-10
Relypsa, Inc.: Series B $70M09-17-10
Tryton Medical, Inc.: Series D $20M09-16-10
Good Start Genetics, Inc.: Series A $18M09-15-10
Sorbent Therapeutics, Inc.: Series B $21M09-14-10
Rhythm Pharmaceuticals, Inc: Series A $19M09-10-10
Alethia Biotherapeutics, Inc: Series A $7M09-08-10
Lineagen, Inc.: Series A $5M09-07-10
Celator Pharmaceuticals, Inc.: Series D $20M09-03-10
Otonomy, Inc.: Series B $38.5M09-02-10
Aptus Endosystems, Inc.: Series D $1509-01-10
EndoGastric Solutions, Inc.: Series F $30M08-31-10
Si-Bone, Inc.: Series B $10.6M08-30-10
Complete Genomics, Inc.: Series E $39M08-27-10
Poxel, SA: Series A $20.3M08-27-10
Gemin X Pharmaceuticals, Inc.: Series E $8M08-24-10
Great Lakes Pharmaceuticals, Inc.: Series B $3.1M08-23-10
Health Market Science, Inc.: Series B $6.1M08-23-10
Solazyme, Inc.: Series D $52M08-20-10
CeNeRx BioPharma, Inc.: Series C $10M08-20-10
TetraLogic Pharmaceuticals, Inc.: Series C $32M08-19-10
Swift Biosciences, Inc.: Series A $3M08-19-10
Dicerna Pharmaceuticals, Inc.: Series B $25M08-18-10
Nephera, Ltd.: Series B $2.8M08-18-10
EndoStim, Inc.: Series B $6M08-17-10
Pantech Biosolutions, AG: Series B $19M08-17-10
Calistoga Pharmaceuticals, Inc.: Series C $40M08-16-10
BarRx Medical, Inc.: Series D $15M08-13-10
Metamark Genetics, Inc.: Series B $22M08-13-10
Trevena, Inc.: Series B $35M08-12-10
TriVascular, Inc.: Series C $60M08-12-10
Ventus Medical, Inc.: Series D $40M08-11-10
Reata Pharmaceuticals, Inc.: Series D $78M08-11-10
Visterra, Inc.: Series A $6M08-10-10
Calithera Biosciences, Inc.: Series A $40M08-09-10
iPierian, Inc.: Series B $22M08-09-10
2Q10 OnBioVC | Trend Analysis Now Available08-02-10
Curexo Technology Corp.: Series C $13.2M07-30-10
Ensysce Biosciences, Inc.: Series A $1.5M07-30-10
Green Biologics, Ltd.: Series B $6.1M07-30-10
Zymeworks, Inc.: Series B $3.2M07-29-10
Molecular Detection, Inc.: Series C $1.4M07-29-10
Zeltiq, Inc.: Series D $25M07-29-10
NanoPowers, SA: Series A $4.5M07-29-10
SynapDx Corp.: Series A $9M07-29-10
Reinnervate, Ltd.: Series A $2M07-28-10
Noxxon Pharma, AG: Series D $40M07-28-10
Palmaz Scientific, Inc.: Series A $3M07-27-10
Phreesia, Inc.: Series D $16M07-27-10
Coskata, Inc.: Series D $23.7M07-26-10
Mirina Corp.: Series A $3.9M07-26-10
EarlySense, Ltd.: Series C $13M07-23-10
BioScale, Inc.: Series D $25M07-22-10
Delphinus Medical Technologies, LLC: Series A $8M07-21-10

SourceSolution © 2008-2012